Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-030017
Filing Date
2023-03-08
Accepted
2023-03-08 13:57:50
Documents
12
Period of Report
2023-03-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm238940d1_6k.htm 6-K 14315
2 EXHIBIT 99.1 tm238940d1_ex99-1.htm EX-99.1 9798
3 EXHIBIT 99.2 tm238940d1_ex99-2.htm EX-99.2 35397
4 GRAPHIC tm238940d1_ex99-1img001.jpg GRAPHIC 3869
5 GRAPHIC tm238940d1_ex99-2img001.jpg GRAPHIC 122610
6 GRAPHIC tm238940d1_ex99-2img002.jpg GRAPHIC 68246
7 GRAPHIC tm238940d1_ex99-2img003.jpg GRAPHIC 112299
8 GRAPHIC tm238940d1_ex99-2img004.jpg GRAPHIC 275817
9 GRAPHIC tm238940d1_ex99-2img005.jpg GRAPHIC 360226
10 GRAPHIC tm238940d1_ex99-2img006.jpg GRAPHIC 347266
11 GRAPHIC tm238940d1_ex99-2img007.jpg GRAPHIC 329262
12 GRAPHIC tm238940d1_ex99-2img008.jpg GRAPHIC 62987
  Complete submission text file 0001104659-23-030017.txt   2379280
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 23715523
SIC: 2833 Medicinal Chemicals & Botanical Products